CANNARA BIOTECH INC (LOVE.CA) Stock Income Statement
Canada - TSX Venture Exchange - TSX-V:LOVE - CA13765U2002 - Common Stock
1.71 CAD
+0.02 (+1.18%)
| 2025 (2025-8-31) | 2024 (2024-8-31) | 2023 (2023-8-31) | 2022 (2022-8-31) | 2021 (2021-8-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 107.32M | 82.15M | 57.56M | 36.00M | 17.27M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Cost Of Goods | 89.72M | 77.51M | 51.13M | 29.68M | 12.74M | |||
| Gross Profit | 17.59M | 4.64M | 6.43M | 6.31M | 4.53M | |||
| Operating Expenses | 25.44M | 22.14M | 15.51M | 12.50M | 10.22M | |||
| Research and Development | 711.20K | 1.12M | 1.03M | 1.26M | 1.91M | |||
| Selling, General, and Administrative Expenses | 23.17M | 19.65M | 13.52M | 10.03M | 7.30M | |||
| Operating Income | -7.85M | -17.51M | -9.08M | -6.19M | -5.69M | |||
| Interest Income/Expense | -3.67M | -5.00M | -4.44M | -2.59M | -1.77M | |||
| Other Income/Expense | -432.20K | -608.80K | -555.80K | -41.10K | -16.20K | |||
| Non Recurring Items | 30.04M | 27.60M | 21.02M | 11.13M | 5.95M | |||
| Income Before Taxes | 18.10M | 4.48M | 6.95M | 2.31M | -1.53M | |||
| Income Tax | 5.02M | -1.95M | N/A | N/A | N/A | |||
| Net Income | 13.08M | 6.44M | 6.95M | 2.31M | -1.53M | |||
| EBITDA | -1.16M | -11.15M | -4.14M | -2.26M | -2.67M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.14 | 0.07 | 0.08 | 0.03 | -0.02 | |||
| Statistics | ||||||||
| Gross Profit Margin | 16.40% | 5.65% | 11.17% | 17.54% | 26.22% | |||
| Profit Margin | 12.18% | 7.84% | 12.07% | 6.40% | -8.85% | |||
| Operating Profit Margin | -7.31% | -21.31% | -15.78% | -17.18% | -32.96% | |||
All data in CAD